Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
EP4 receptor antagonist
p110α inhibitor.
Benzophenanthridine alkaloid; topoisomerase I i...
Aurora kinase A inhibitor.
Retinol (vitamin A) analog, binds RBP4; Des1 in...
Bioactive compound from olive tree.
Electrophile used in 2’-hydroxyl acylation of...
Laminin-derived hexapeptide.
Endogenous peptide hormone fragment, involved i...
Metabolite of spironolactone; Na+/K+ ATPase par...
BHA derivative, cellular differentiation induce...
PKC activator, carcinogen.
Lectin found in Canavelia, plant mitogen that b...
Toll-like receptor 7/8 agonist
AChE inhibitor, F0F1-ATP synthase modulator.
Found in the propolis of honey bees.
Xanthine oxidase inhibitor.
NSAID; PG synthetase inhibitor.
LRRK2 inhibitor.
p110α PI3K and mTOR inhibitor.